Professor
Michael von Bergwelt
Hematologist, Oncologist, Infectologist
About the doctor
Profile
Treatment of leukemias and other hematologic malignancies (lymphomas, myeloma, MDS), management of sarcomas (bone and soft tissue), systemic therapy for gastrointestinal cancers (colorectal, gastric, pancreatic, liver), stem cell transplantation (autologous and allogeneic), immunotherapy, targeted therapy, and chemotherapy, psycho-oncology support integrated into cancer care, treatment of bone marrow failure syndromes and benign hematologic disorders
Work experience
33 years
Scientific activity
Author of over 400 peer-reviewed scientific publications in hematology, oncology, and cellular immunotherapy
Key contributor to national and international clinical trials in CAR-T therapy, checkpoint inhibitors, and transplant optimization
We combine cutting-edge science with compassionate care—offering patients access to innovative therapies while supporting their physical and emotional well-being.
Data
Member of the Executive Board, Comprehensive Cancer Center Munich (CCC Munich) — a joint initiative of Ludwig-Maximilians-Universität (LMU) Munich and Technical University of Munich (TUM)
Director, Medical Clinic and Polyclinic III, University Hospital LMU Munich — a leading center for hematology, oncology, and stem cell transplantation
Consistently ranked among Germany’s Top 100 Oncologists by FOCUS magazine
Community
European Society for Blood and Marrow Transplantation (EBMT)
German Consortium for Translational Cancer Research (DKTK) — Chairman (since 2020)
Oncology Steering Committee (OSC)
German Society for Hematology and Medical Oncology (DGHO)
American Society of Hematology (ASH)
European Hematology Association (EHA)